Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremity

被引：36

作者：

Ann BI Bremander

Ingemar F Petersson

Ewa M Roos

机构：

[1] Center for Research and Development, Spenshult Hosp. for Rheumatic Dis.

[2] Department of Orthopedics, Lund University Hospital

来源：

Health and Quality of Life Outcomes | / 1卷 / 1期

关键词：

Health Assessment Questionnaire; Health Assessment Questionnaire Score; Inflammatory Joint Disease; Assess Construct Validity; Multidisciplinary Team Care;

D O I：

10.1186/1477-7525-1-55

中图分类号：

学科分类号：

摘要：

Background: Patients with inflammatory joint diseases tend due to new treatments to be more physically active; something not taken into account by currently used outcome measures. The Rheumatoid and Arthritis Outcome Score (RAOS) is an adaptation of the Knee injury and Osteoarthritis Outcome Score (KOOS) and evaluates functional limitations of importance to physically active people with inflammatory joint diseases and problems from the lower extremities. The aim of the study was to test the RAOS for validity, reliability and responsiveness. Methods: 119 in-patients with inflammatory joint disease (51% RA) admitted to multidisciplinary care, mean age 56 (±13), 73% women, mean disease duration 18 (±14) yr were consecutively enrolled. They all received the RAOS, the SF-36, the HAQ and four subscales of the AIMS2 twice during their stay for test of validity and responsiveness. Test-retest reliability of the RAOS questionnaire was calculated on 52 patients using the first or second administration and an additional mailed questionnaire. Results: The RAOS met set criteria of reliability and validity. The random intraclass correlation coefficient (ICC 2,1) for the five subscales ranged from 0.76 to 0.92, indicating that individual comparisons were possible except for the subscale Sport and Recreation Function. Inter-item correlation measured by Cronbach's alpha ranged from 0.78 to 0.95. When measuring construct validity the highest correlations occurred between subscales intended to measure similar constructs. Change over time (24 (± 7) days) due to multidisciplinary care was significant for all subscales (p < 0.001). The effect sizes ranged from 0.30 - 0.44 and were considered small to medium. All the RAOS subscales were more responsive than the HAQ. Some of the SF-36 subscales and the AIMS2 subscales were more responsive than the RAOS subscales. Conclusion: It is possible to adapt already existing outcome measures to assess other groups with musculoskeletal difficulties in the lower extremity. The RAOS is a reliable, valid and responsive outcome instrument for assessment of multidisciplinary care. To fully validate the RAOS further studies are needed in other populations. © 2003 Bremander et al; licensee BioMed Central Ltd.

引用

页数：11

共 36 条

[1] Benedek Thomas G., History of the Rheumatic Diseases, Primer on the Rheumatic Diseases, (1997)
[2] Geborek P., Crnkic M., Petersson I.F., Saxne T., Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: Clinical experience using a structured follow up programme in southern Sweden, Ann. Rheum. Dis., 61, pp. 793-798, (2002)
[3] Jones G., Halbert J., Crotty M., Shanahan E.M., Batterham M., Ahern M., The effect of treatment on radiological progression in rheumatoid arthritis: A systematic review of randomized placebo-controlled trials, Rheumatology (Oxford), 42, pp. 6-13, (2003)
[4] Pincus T., Ferraccioli G., Sokka T., Larsen A., Rau R., Kushner I., Wolfe F., Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: Updating a 1983 review, Rheumatology (Oxford), 41, pp. 1346-1356, (2002)
[5] Guillemin F., Functional disability and quality-of-life assessment in clinical practice, Rheumatology (Oxford), 39, SUPPL. 1, pp. 17-23, (2000)
[6] Liang M.H., Longitudinal construct validity: Establishment of clinical meaning in patient evaluative instruments, Med. Care, 38, pp. 1184-1190, (2000)
[7] Roos E.M., Roos H.P., Lohmander L.S., Ekdahl C., Beynnon B.D., Knee Injury and Osteoarthritis Outcome Score (KOOS) - Development of a self-administered outcome measure, J. Orthop. Sports Phys. Ther., 28, pp. 88-96, (1998)
[8] Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W., Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J. Rheumatol., 15, pp. 1833-1840, (1988)
[9] Roos E.M., Roos H.P., Ekdahl C., Lohmander L.S., Knee injury and Osteoarthritis Outcome Score (KOOS) - Validation of a Swedish version, Scand. J. Med. Sci. Sports, 8, pp. 439-448, (1998)
[10] Roos E.M., Roos H.P., Lohmander L.S., WOMAC Osteoarthritis Index - Additional dimensions for use in subjects with post- traumatic osteoarthritis of the knee, Osteoarthritis Cartilage, 7, pp. 216-221, (1999)

← 1 2 3 4 →